Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 3.05x as of 2026-10-06T13:22:01.388Z.
Calculation as of: 2026-10-06T13:22:01.388Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
3.05x
SECTOR MEDIAN · HEALTHCARE
1.62x
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
+88.27%
vs the sector median at left
Generate Biomedicines, Inc.
Market Cap
$1.78B
EV/Assets Ratio
3.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
EV/Assets Ratio
2.04x
TTM Avg
1.71x
3Y Avg
1.54x
5Y Avg
2.46x
Market Cap
$1.76B
EV/Assets Ratio
1.09x
TTM Avg
3.01x
3Y Avg
2.73x
5Y Avg
2.56x
Market Cap
$1.83B
EV/Assets Ratio
1.05x
TTM Avg
0.97x
3Y Avg
1.37x
5Y Avg
1.49x
Market Cap
$1.71B
EV/Assets Ratio
0.73x
TTM Avg
0.81x
3Y Avg
0.94x
5Y Avg
1.07x
Market Cap
$1.87B
EV/Assets Ratio
1.62x
TTM Avg
1.45x
3Y Avg
1.64x
5Y Avg
1.44x
Market Cap
$1.89B
EV/Assets Ratio
4.20x
TTM Avg
3.16x
3Y Avg
2.72x
5Y Avg
2.41x
Market Cap
$1.66B
EV/Assets Ratio
4.80x
TTM Avg
3.71x
3Y Avg
4.46x
5Y Avg
4.46x
Market Cap
$1.65B
EV/Assets Ratio
1.08x
TTM Avg
1.25x
3Y Avg
1.33x
5Y Avg
1.28x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.78B | 3.05x | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 2.04x | 1.71x | 1.54x | 2.46x |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.09x | 3.01x | 2.73x | 2.56x |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05x | 0.97x | 1.37x | 1.49x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 0.73x | 0.81x | 0.94x | 1.07x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 1.62x | 1.45x | 1.64x | 1.44x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 4.20x | 3.16x | 2.72x | 2.41x |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | 4.80x | 3.71x | 4.46x | 4.46x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 1.08x | 1.25x | 1.33x | 1.28x |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 2.70x | 3.05x | 2.78x | 2.75x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
